These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21710803)
61. Induction of lactation in infertile cattle using synthetic steroid compounds. Dabas YP; Sud SC Indian J Exp Biol; 1990 Jun; 28(6):594-6. PubMed ID: 2401533 [No Abstract] [Full Text] [Related]
62. [Drugs for 'neglected diseases': a bitter pill]. Veeken H; Pécoul B Ned Tijdschr Geneeskd; 2000 Jun; 144(26):1253-6. PubMed ID: 10908954 [TBL] [Abstract][Full Text] [Related]
63. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Society for Maternal Fetal Medicine Publications Committee Obstet Gynecol; 2008 Oct; 112(4):963-5. PubMed ID: 18827143 [No Abstract] [Full Text] [Related]
64. Gestiva for preventing prematurity: a new view of an old therapy. Cypher R Nurs Womens Health; 2007 Jun; 11(3):322-5. PubMed ID: 17883780 [No Abstract] [Full Text] [Related]
65. Neglected diseases get vaccine research boost. Abbott A Nature; 2008 Feb; 451(7182):1037. PubMed ID: 18305506 [No Abstract] [Full Text] [Related]
66. For appearance only. Wood G Am Pharm; 1989 Feb; NS29(2):5. PubMed ID: 2929420 [No Abstract] [Full Text] [Related]
67. Remedies for tropical diseases. Garattini S Lancet; 1988 Jun; 1(8598):1338. PubMed ID: 2897585 [No Abstract] [Full Text] [Related]
69. [Effect of treatment with synthetic progestins on indices of the liver protein-forming function in uterine cancer patients]. Shvedova LA Akush Ginekol (Mosk); 1984 Apr; (4):51-2. PubMed ID: 6742352 [No Abstract] [Full Text] [Related]
70. Global health or global wealth? Rezaie R; Singer PA Nat Biotechnol; 2010 Sep; 28(9):907-9. PubMed ID: 20829824 [No Abstract] [Full Text] [Related]
71. Masters of efficiency. Hoag H Nature; 2006 Sep; 443(7107):116-7. PubMed ID: 17001767 [No Abstract] [Full Text] [Related]
73. New definition of term pregnancy. Nicholson JM; Kellar LC; Ural S JAMA; 2013 Nov; 310(18):1985-6. PubMed ID: 24219957 [No Abstract] [Full Text] [Related]
74. [Orphan drugs]. Hem E; Madsen S Tidsskr Nor Laegeforen; 2016 Feb; 136(3):241. PubMed ID: 26860385 [No Abstract] [Full Text] [Related]
75. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP. Armstrong J N Engl J Med; 2011 May; 364(18):1689-91. PubMed ID: 21410391 [No Abstract] [Full Text] [Related]
76. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth. Calda P J Matern Fetal Neonatal Med; 2009 Jun; 22(6):540-2. PubMed ID: 19089768 [No Abstract] [Full Text] [Related]
77. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. O'Brien JM Obstet Gynecol; 2012 Feb; 119(2 Pt 1):384-5; author reply 385-6. PubMed ID: 22270303 [No Abstract] [Full Text] [Related]
78. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate. Bailit JL; Votruba ME Am J Obstet Gynecol; 2007 Mar; 196(3):219.e1-7. PubMed ID: 17346527 [TBL] [Abstract][Full Text] [Related]
79. What is in a name? A higher cost! Hansen KA S D Med; 2011 Jun; 64(6):194-5. PubMed ID: 21710803 [No Abstract] [Full Text] [Related]